E Fund Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,012	Closed	-$216K	–	345
2022 Q3	$216K	Sell	4,012 -1,151	-22%	-$62K	0.02%	292
2022 Q2	$287K	Buy	5,163 +1,317	+34%	+$73.2K	0.03%	241
2022 Q1	$270K	Buy	+3,846	New	+$270K	0.01%	235